ArticleWorld journal of gastroenterology2008
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
Article in World journal of gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Concurrent moxifloxacin-induced liver injury and toxic epidermal necrolysis after immune checkpoint inhibition: a case report and literature review.Frontiers in immunology · 2026Pooled it
- Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome.Internal medicine (Tokyo, Japan) · 2024Article
- Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis.Infection · 2024Article
- Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis.Internal medicine (Tokyo, Japan) · 2024Article
- Culprit Medications and Risk Factors Associated with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case-Control Study.American journal of clinical dermatology · 2022Article
- Infliximab-Induced Vanishing Bile Duct Syndrome.Cureus · 2022Article
- Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis.Frontiers in medicine · 2022Article
- Successful liver transplantation for drug-induced vanishing bile duct syndrome.BMJ case reports · 2020Article
- Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Clinical reviews in allergy & immunology · 2018Review
- Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis.ACG case reports journal · 2018Article
- Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.Pediatrics · 2014Review
- Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant.Yonsei medical journal · 2014Article
- Fluoroquinolone-induced liver injury: three new cases and a review of the literature.European journal of clinical pharmacology · 2012Review
- Drug-induced cholestasis.Hepatology (Baltimore, Md.) · 2011Review
- Tacrolimus (FK506): Safety and Applications in Reconstructive Surgery.Hand (New York, N.Y.) · 2010Article
- Successful Treatment of Stevens-Johnson Syndrome with Cyclosporine and Corticosteroid.The Canadian journal of hospital pharmacyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stevens-Johnson syndrome (SJS) is a serious and potentially life-threatening disease. Vanishing bile duct syndrome (VBDS) is a rare cause of progressive cholestasis. Both syndromes are mostly related with drugs. We report a case of a patient with ciprofloxacin-induced SJS and acute onset of VBDS, and reviewed the related literature. It is the first case of ciprofloxacin-induced VBDS successfully treated with tacrolimus. This case reminds physicians of the importance of drug reactions, their severity, techniques for diagnosis and methods of management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.